There is no shortage of medication provided under the Chronic Disease Assistance Programme (CDAP). This was disclosed yesterday by Health Minister Therese Baptiste-Cornelis at the ministry's Christmas luncheon at the Hyatt Regency, Port-of-Spain. She was responding to a newspaper report (not the T&T Guardian) yesterday which claimed some pharmacies had reported a shortage of drugs listed in the CDAP, such as Timolol used to treat glaucoma.
Baptiste-Cornelis said she was "alarmed" by the report and contacted the National Insurance Property Development Company Ltd (Nipdec), the body responsible for ordering pharmaceuticals on behalf of the ministry for the programme. She said Nipdec informed her there was no shortage and provided her with a press release dismissing the report.
Quoting Nipdec's release, Baptiste-Cornelis explained that some pharmacies experienced difficulties getting supplies from Nipdec's central stores over the last few months. That had nothing to do with drug shipments but was a result of adverse effects experienced by staff after the facility was sprayed. Baptiste-Cornelis said despite having to deviate from its normal pattern of distribution, Nipdec assured that all emergency and priority orders were fulfilled.
She said in regards to the availability of Timolol eye drops, Nipdec said there were adequate supplies in the system until the end of November 2010. Baptiste-Cornelis said Nipdec informed her that a new shipment arrived in November but due to the Christmas rush, the drug was only cleared off the port last Monday. She said all pharmacies in need of the eye drops would receive them today. Baptiste-Cornelis said pharmacies named in the newspaper report contacted the ministry yesterday to dispel statements made in the report and confirmed they had received CDAP supplies.
